NCT02307630View on ClinicalTrials.gov

PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study

NAActive, not recruitingINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

MelanomaNeuroblastomaSarcoma

Interventions

BIOLOGICAL

124I-Humanized 3F8

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Y-mAbs Therapeutics

All Listed Sponsors

collaborator

Y-mAbs Therapeutics

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02307630 - PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study | Biotech Hunter | Biotech Hunter